NASDAQ

enGene Therapeutics Inc. (ENGN)

♥ 559 Thanks from members

Live price chart, market sentiment, and community perspectives for enGene Therapeutics Inc. (NASDAQ: ENGN).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Madhu CherukuriFounder: Yoshiyuki KatoLeadership: JasonInterfaces (CEO)Leadership: Roger Sawhney (CFO)Holder: Pontifax MedTechHolder: RA Capital ManagementHolder: FMR LLCdetalimogene voraplasmid (EG-70)Non-viral gene delivery platform (TME)#ENGN#enGene Therapeutics#gene therapy#bladder cancer treatment#NASDAQ biotech